There is a hard stop to the change process, from 1st April the system will be operable, and the products registered at that point will decide the fees payable for 2026/27. So, there are a number of actions manufacturers and UKRPs will need to consider.
To place medical devices onto the UK market manufacturers must register with the MHRA and register all relevant products, registration must be active when each batch of product is placed on the market. For manufacturers based outside the Uk this is done via the UKRP.
It is probably true that there are no two pharmaceutical wholesales that are the same, but the variation out there is also probably a little surprising.
Following a government consultation, updated guidance on the application and implications of Intellectual Property (IP) restrictions has been published. Essentially there is no change to the rules that were established following Brexit, but it is important for businesses who participate in this trading style are aware of the rules.
At various points over the last few years we have heard the cry of ‘let’s just get Brexit done’. Given that it is over 8 years since the public vote, it would be good to think we are somewhere near closing out the loose ends.
